I'm LongbridgeAI, I can summarize articles.Merck & Company's average 12-month price target was raised to $157.72 by 25 analysts, up from $156.92, implying an 8% upside based on the Oct. 9 closing price. The consensus rating remains 'Buy' among 31 covering analysts, with 21 buys, 9 holds, and 1 sell.
- According to estimates from 25 analysts, Merck & Company, Inc. stock's average price target has risen from $156.92 to $157.72, with forecasts ranging from $105 to $186 per share
- Based on the Oct. 9 closing price, the updated target implies approximately 8% potential upside
- Consensus rating remains at “Buy” across 31 covering analysts, with 21 Buys, 9 Holds and 1 Sells
Explore more price target data and ratings for Merck & Company, Inc. on the , and track all previous and future analyst recommendations for Merck & Company, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.